INTRODUCTION {#sec1}
============

A significant number of preoperatively hospitalised patients are malnourished. It ranges from 1.2 to 46.4% among cardiac surgery patients ([@ref1]--[@ref12]). Despite that, malnutrition is frequently neglected and not diagnosed in time. This leads to increased morbidity, mortality and impaired quality of life ([@ref12]--[@ref15]). These deleterious outcomes are responsible for increased hospital costs and a greater need for rehabilitation ([@ref16]). A precise and timely nutritional state assessment would enable malnourished patients at a higher risk of post-operative complications to be identified. As a result, this could reduce both the incidence of adverse clinical outcomes and the treatment cost.

Bioelectrical impedance analysis (BIA) is a method of assessing body composition and nutritional status using impedance data of the tissues. Specific prediction equations for the estimation of the body compartments (e. g. fat mass (FM) and fat free mass (FFM)) have been developed and validated using gold standard techniques such as dual-energy X-ray absorbmetry (DEXA) for healthy populations ([@ref17]). The point at issue is that predictive BIA equations might cause significant errors in some pathological states. Therefore the application of raw impedance data (e. g. reactance, resistance and phase angle (PA)) may have greater accuracy and potency in nutritional state evaluation ([@ref18]). This assumption is grounded by measuring the phase angle, which has been reported to be an indicator of adverse clinical outcomes and malnutrition in various conditions ([@ref19], [@ref20]).

Cardiac surgery patients are in a poor nutritional state because the body composition is altered by the changes occurring in acute and chronic disease ([@ref21]). Moreover, these patients are lacking in uptake or intake of nutrition and frequently have an impaired neurophysiological status or physical mobility ([@ref22], [@ref23]). Heart failure patients are not physically active because of the disease, and the disease progresses further because of the lack of exercise. Furthermore, a longer time spent in the hospital before surgery reduces physical activity ([@ref24]). Hospitalised patients suffer from high levels of anxiety and depression, which adversely affect their nutritional habits before surgery ([@ref25]). Thus, the nutritional state deteriorates further for preoperatively hospitalised patients.

Even though the conventional factors of malnutrition are well known and their use is well established in the European Society for Clinical Nutrition and Metabolism (ESPEN) recommended guidelines on malnutrition diagnostics ([@ref26]), there are no studies that can provide specific preoperative malnutrition risk factors for cardiac surgery patients. Therefore, the aim of this study is to assess the early, specific and clinically relevant risk factors of malnutrition for cardiac surgery patients.

MATERIALS AND METHODS {#sec2}
=====================

Patients {#sec2_1}
--------

An observational study was conducted in a tertiary referral university hospital between March 2013 and March 2014. Ethical approval for this study (Ethical Committee N°158200-12-561-162) was provided by the Vilnius Regional Biomedical Research Ethics Committee, Vilnius, Lithuania, on 29 November 2012.

During this period, data regarding patients undergoing elective cardiac surgery were gathered. The only patients excluded from the study were those who did not agree to participate or had impaired mental function and could not give an informed consent.

Nutritional state evaluation {#sec2_2}
----------------------------

The nutritional state of the patients was evaluated one day prior to surgery. BIA was performed using an InBody S10 (Biospace, Seoul, Korea) body composition analyser. The device was calibrated prior to the study and set to use a Caucasian population reference equation for the analysis. During the analysis the patients were in a supine position with arms abducted 15 degrees from the trunk and legs spread apart at the shoulder width and according to all other recommendations of the ESPEN and the manufacturers ([@ref27]).

The measurement of the PA was obtained from BIA and was used to evaluate the nutritional state of the patients ([@ref28]). The mean segmental PA of the 50 kHz frequency was used to classify patients into groups of the nutritional state according to the age and gender reference values of the healthy subjects ([@ref29]). This step allowed the physiological changes of the body composition occurring in women and elderly patients, which result in lower but not pathological values of the PA, to be accounted for. The low PA margin was set at the 15th percentile of the mean population reference values, generating two groups of patients: malnourished and wellnourished ([@ref30]). The age and gender adjusted cut-off values of the PA are presented in the [Figure](#fig1){ref-type="fig"}.

Assessment of risk factors {#sec2_3}
--------------------------

Preoperative variables expected to be associated with the development of preoperative malnutrition were obtained during a preoperative interview with the patients and using chart records. These variables included the questions asked in the ESPEN recommended nutrition risk screening questionnaires, Nutritional Risk Screening 2002 (NRS-2002), Malnutrition Universal Screening Tool (MUST) and Mini Nutritional Assessment (MNA), and various clinical parameters and co-morbidities presented in [Table 1](#T1){ref-type="table"} ([@ref26]). These variables were divided into three clinically relevant groups of malnutrition risk factors: psychosocial and lifestyle factors, laboratory findings and disease-associated factors ([@ref31]). The psychosocial and lifestyle factors encompassed the intake of food and weight loss, the presence of depresssion and neurophysiological problems, the severity of the chronic disease, mood disorders and impaired mobility as defined in the latter questionnaires. The laboratory values tested were those indicating chronic inflammation, impaired haemopoiesis and other most clinically relevant parameters for cardiac surgery patients. The disease-associated factors group was generated by employing all of the most prevalent co-morbidities for the patients in question and by adding the hospitalisation and demographic parameters ([@ref32]).

Statistical analysis {#sec2_4}
--------------------

Descriptive statistics were used to describe the baseline characteristics. The data is presented using the median and interquartile range \[IQR\] of the sample.

The distribution of low PA predictors between the two independent normally and non-normally distributed data sets was evaluated using Student-t and Mann--Whitney U tests, respectively. The differences between independent two qualitative data groups were evaluated by the Chi-squared test.

Variables in each different group of low PA risk factors were entered into a univariate logistic regression model. Each group's factors found to be significant in the univariate logistic regression analysis were entered into three different multivariate logistic regression models with the forward model selection process.

A two-tailed *p*-value of less than 0.05 was considered to be significant. Statistical analysis was performed using the Statistical Analysis System (SAS) package version 9.2 and the statistical tools package IBM SPSS Statistics v21.

RESULTS {#sec3}
=======

Baseline characteristics of the patients {#sec3_1}
----------------------------------------

Seven hundred and twelve patients were included in the study. The majority of the patients were men with low operative risk. The median age of the study group was 65 years. Two-thirds of the hospitalised patients were scheduled to have CABG surgery. The most common co-morbidities in the study population were hypertension, myocardial infarction, rhythm abnormalities and diabetes. Almost all of the patients had second- or third-class cardiac congestion symptoms defined by the NYHA. These and other baseline characteristics are presented in [Table 1](#T1){ref-type="table"}.
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###### 

Baseline characteristics of the patients and comparison of low PA and normal PA groups

                                        Overall N = 712          Low PA group N = 163 (22.9%)   Normal PA group N = 549 (77.1%)   *P* value
  ------------------------------------- ------------------------ ------------------------------ --------------------------------- -----------
  **Factor**                            n (%) or M \[IQR\]       Median \[IQR\] or mean ± SD                                      
  **Patients**                                                                                                                    
  Age, years                            65 \[58--73\]            64.98 ± 12.35                  64.39 ± 10.46                     0.584
  Gender: Male (% within male)          471 (66.2)               96 (20.4)                      375 (79.6)                        0.026
  Female (% within female)              241 (33.8)               67 (27.8)                      174 (72.2)                        
  **Hospitalisation length**                                                                                                      
  Before surgery, days                  6 \[3--9\]               12.5 \[3.75--19.75\]           7 \[4--10\]                       0.020
  **Nutrition markers**                                                                                                           
  PA, °                                 5.5 \[4.9--6.14\]        4.46 ± 0.60                    5.84 ± 0.75                       \<0.000
  FFMI, kg/m^2^                         19.26 \[17.43--20.86\]   17.99 ±2.27                    19.66 ± 2.34                      \<0.001
  Low FFMI                              61 (8.6)                 34 (20.9)                      27 (5.0)                          \<0.001
  BMI, kg/m^2^                          28.23 \[25.28--31.64\]   27.65 ± 5.46                   29.14 ± 4.74                      0.001
  Unintended weight loss \> 5%, n (%)   165 (23.2)               50 (40.3)                      115 (27.1)                        0.005
  **Co-morbidities**                                                                                                              
  Smoking, n (%)                        135 (19.0)               34 (21.0)                      101 (18.5)                        0.495
  Hypertension, n (%)                   554 (78.1)               118 (72.8)                     436 (79.7)                        0.063
  Peripheral artery disease, n (%)      96 (13.6)                23 (14.2)                      73 (13.4)                         0.787
  COPD, n (%)                           36 (5.1)                 9 (8.2)                        27 (27.8)                         0.689
  Renal failure, n (%)                  42 (5.9)                 19 (11.8)                      23 (4.2)                          \<0.001
  Oncologic disease, n (%)              56 (7.9)                 16 (9.9)                       40 (7.3)                          0.288
  MI, n (%)                             255 (36.0)               58 (35.8)                      197 (36.0)                        0.961
  MI \< 30 days, n (%)                  84 (11.9)                20 (12.3)                      64 (11.7)                         0.829
  Rhythm abnormalities, n (%)           168 (23.7)               47 (29.0)                      121 (22.1)                        0.070
  Diabetes, n (%)                       151 (21.2)               40 (24.7)                      111 (20.3)                        0.230
  Stroke, n (%)                         69 (9.7)                 20 (12.3)                      49 (9.0)                          0.201
  Psychological disease, n (%)          5(0.7)                   0 (0.0)                        5 (3.9)                           0.594
  Gastric erosions, n (%)               170 (24.0)               32 (19.8)                      138 (25.2)                        0.152
  NYHA class, n (%)                                                                                                               
  I                                     6 (0.9)                  3 (1.9)                        3 (0.6)                           \<0.001
  II                                    77 (11.3)                15 (9.6)                       62 (11.8)                         
  III                                   562 (82.3)               120 (76.4)                     442 (84.0)                        
  IV                                    38 (5.6)                 19 (12.1)                      19 (3.6)                          
  **Echocardiography**                                                                                                            
  LVEF                                  50.43 \[45--55\]         55 \[40--55\]                  55 (49--55\]                      0.055
  LVEF \< 30 mmHg, n (%)                41 (6.0)                 17 (11.0)                      24 (4.6)                          0.006
  LVED diameter, cm                     5.3 \[5.0--5.8\]         5.50 ± 0.89                    5.40 ± 0.70                       0.181
  Enlarged LV, n (%)                    195 (29.0)               56 (36.6)                      139 (26.8)                        0.019
  AVI ≥ III°, n (%)                     35 (4.9)                 14 (8.6)                       21 (3.8)                          0.022
  AVS ≥ II°, n (%)                      94 (13.3)                23 (14.1)                      71 (13.0)                         0.715
  MVI ≥ II°, n (%)                      156 (22.0)               50 (30.7)                      106 (19.4)                        0.002
  TVI ≥ II°, n (%)                      82 (11.6)                28 (17.2)                      54 (9.9)                          0.011
  **Laboratory values**                                                                                                           
  Glucose, mmol/L                       5.83 \[5.03--6.94\]      6.14 ± 1.29                    6.34 ± 2.47                       0.830
  Haemoglobin, g/L                      139 \[128--149\]         130.26 ± 16.34                 139.76 ± 15.38                    \<0.001
  Haematocrit (ratio)                   0.41 \[0.38--0.43\]      0.39 ± 0.47                    0.41 ± 0.44                       \<0.001
  Platelet count, 10^9^/L               206.0 \[175.8--248.0\]   205 \[193.8--324.3\]           211 \[186--263\]                  0.031
  WBC (10^9^/L)                         7.18 \[5.90--8.42\]      7.86 ± 3.35                    7.29 ± 2.05                       0.066
  Troponin level, ng/ml                 0.39 \[0.01--1.90\]      1.44 \[0.00--3.06\]            0.44 \[0.01--1.40\]               0.143
  Creatinine level, pmol/l              82 \[72--97\]            95 \[74.8--119.8\]             81 \[70--106\]                    0.805
  CRP, mg/L                             3.25 \[1.3--9.4\]        10.2 \[5.65--15.8\]            2.6 \[1.58--9.2\]                 \<0.000
  **Operative risk**                                                                                                              
  Euroscore II                          1.77 \[1.06--2.49\]      2.44 \[1.12--6.60\]            2.00 \[1.41--2.96\]               \<0.000
  **Operative procedure**                                                                                                         
  STS CABG, n (%)                       423 (60.3)               87 (53.4)                      336 (62.5)                        0.038
  STS valve, n (%)                      234 (33.4)               59 (36.2)                      151 (28.1)                        0.051
  STS combined, n (%)                   24 (3.4)                 4 (2.5)                        20 (3.7)                          0.623
  STS other, n (%)                      44 (6.3)                 13 (8.0)                       31 (5.8)                          0.307
  Not operated, n (%)                   11 (1.5)                 0 (0.0)                        11 (2.0)                          0.078

Values are presented in absolute numbers and rates for categorical factors and for continuous factors by median (M) and interquartile range (IQR) in brackets.

Abbreviations: PA, phase angle; Low PA, low phase angle; SD, standard deviation; BMI, body mass index; CI, confidence interval; CAD, coronary artery disease; OP, operation; LVEF, left ventricle ejection fraction; LV, left ventricle; AVI, aortic valve insufficiency; MVI, mitral valve insufficiency; TVI, tricuspid valve insufficiency; WBC, white blood count; CRP, C-reactive protein; NRS 2002, Nutritional Risk Screening 2002; MUST, Malnutrition Universal Screening Tool; MNA, Mini Nutritional Assessment; Q, question; STS, Society of Thoracic Surgeons.

Nutritional state evaluation {#sec3_2}
----------------------------

Low PA was present in 163 (22.9%) patients. In this group the rates of low FFMI and unintended weight loss were higher. The incidence of low PA was higher within women and renal failure patients. Furthermore, higher rates of low PA were present in patients with cardiac congestion and enlarged ventricles and in those with valve pathology. Also, the median values of the inflammation and anaemia markers were noted to be higher in the low PA group ([Table 1](#T1){ref-type="table"}). These and other possible risk factors of malnutrition were entered into the regression analysis of the low PA risk factors.

Risk factors of malnutrition {#sec3_3}
----------------------------

The univariate and multivariate logistic regression analysis of low PA risk factors is presented in [Table 2](#T2){ref-type="table"}.

Analysis of various co-morbidities and disease- related factors of malnutrition revealed the importance of heart functions and valve pathology in the development of cardiac cachexia. NYHA IV class heart insufficiency, mitral valve insufficiency and renal failure were revealed as the most potent predictors of low PA, increasing the risk of malnutrition from two to four times. Moreover, the preoperative body mass index was also indicated as a predictor of malnutrition.

The laboratory values related to low PA were blood serum levels of haemoglobin (Hgb), C-reactive protein (CRP) and platelet count. Decreased Hgb was strongly related to low PA, increasing the risk of malnutrition twofold for every 30 g/L decrease of its value. Whilst the reported effect of platelets on malnutrition was minor, the effect of CRP was unquestionable, increasing the risk of low PA by 50% for every 33 mg/L increase of its value.

###### 

Univariate and multivariate logistic regression analysis of low PA risk factors

  Variable                                           Odds ratio   *P* value   Odds ratio   *P* value                           
  -------------------------------------------------- ------------ ----------- ------------ ----------- ------- ------- ------- ---------
  **Disease-associated factors**                                                                                               
  Gender (male)                                      0.665        0.464       0953         0.0263                              n\. s.
  BMI, kg/m^2^                                       0.936        0.901       0.973        0.0008      0.928   0.890   0.968   \<0.001
  CAD                                                0.643        0.446       0.927        0.0179                              n\. s.
  Renal failure                                      3.049        1.616       5.747        0.0006      4.091   1.995   8.389   \<.0001
  Days prior to OP                                   1.037        1.003       1.073        0.0316                              n\. s.
  NYHA IV class                                      3.681        1.898       7.136        \<0.001     3.073   1.416   6.668   0.005
  LVEF \< 30%                                        2.564        1.340       4.902        0.0044                              n\. s.
  Enlarged LV                                        1.577        1.078       2.315        0.0192                              n\. s.
  AVI ≥ III°                                         2.353        1.168       4.739        0.0166                              n\. s.
  MVI ≥ II°                                          1.842        1.241       2.732        0.0024      1.825   1.182   2.819   0.007
  TVI ≥ II°                                          1.887        1.149       3.096        0.0119                              n\. s.
  **Laboratory values**                                                                                                        
  Haemoglobin, g/L                                   0.964        0.951       0.976        \<.0001     0.967   0.951   0.983   \<.0001
  Platelet count 10^9^/L                             1.004        1.001       1.007        0.0060      1.004   1.000   1.008   0.0338
  WBC 10^9^/L                                        1.092        1.013       1.178        0.0218                              n\. s.
  CRP, mg/L                                          1.020        1.008       1.032        0.0007      1.015   1.002   1.028   0.0279
  **Lifestyle and psychosocial factors**                                                                                       
  NRS 2002 reduced dietary intake in the last week   1.669        1.038       2.681        0.0343                              n\. s.
  NRS 2002 impaired nutritional status:                                                                                        
  Mild (score 1)                                     1.001        0.001       1.667        0.9978                              n\. s.
  Moderate (score 2)                                 3.077        1.603       5.882        0.0007                              n\. s.
  Severe (score 3)                                   1.795        0.001       4.310        0.1883                              n\. s.
  NRS 2002 severity of disease:                                                                                                
  Mild (score 1)                                     2.105        1.294       3.165        0.0020                              n\. s.
  Moderate (score 2)                                 1.520        1.010       4.386        0.0469                              n\. s.
  Severe (score 3)                                   10.753       0.000       14.925       0.7187                              n.s
  MUST acute disease effect                          2.169        1.107       100.000      0.0406                              n\. s.
  MNA QA (intake of food):                                                                                                     
  Moderate decrease                                  3.690        1.280       3.676        0.0040      1.848   1.068   3.205   0.0280
  Severe decrease                                    2.169        1.692       8.065        0.0010      3.030   1.353   6.757   0.0070
  MNA QC (mobility):                                                                                                           
  Able to get out of bed/chair                       3.717        1.393       3.378        0.0006      1.802   1.131   2.874   0.0133
  Bed or chair bound                                 1.821        1.486       9.259        0.0050      2.770   1.067   7.194   0.0364
  MNA QD (psychological stress)                      1.996        1.217       2.732        0.0036                              n\. s.
  MNA QE (neuropsychological problems):                                                                                        
  Mild dementia                                      1.272        1.149       3.460        0.0141                              n\. s.
  Severe dementia or depression                      1.001        0.338       4.785        0.7219                              n\. s.

n\. s. is not significant with *P* value below 0.05.

n\. s., not significant with *P* value below 0.05; CI, confidence interval; BMI, body mass index; CAD, coronary artery disease; OP, operation; LVEF, left ventricle ejection fraction; LV, left ventricle; AVI, aortic valve insufficiency; MVI, mitral valve insufficiency; TVI, tricuspid valve insufficiency; WBC, white blood count; CRP, C-reactive protein; NRS 2002, Nutritional Risk Screening 2002; MUST, Malnutrition Universal Screening Tool; MNA, Mini Nutritional Assessment; Q, question.

Univariate analysis of lifestyle and psychosocial factors represented as questions from the malnutrition screening questionnaires revealed all three of these tools as potent predictors of low PA. However, the multivariate analysis results favoured the answers from the MNA questionnaire. The questions qualified as risk factors of malnutrition concerned the intake of food and the mobility of the patient. The answers to these questions resulted in an overall increase of malnutrition risk from two to three times, depending on the severity of the patients' answers.

DISCUSSION {#sec4}
==========

This study investigated the possible risk factors of preoperative MN in a group of cardiac surgery patients. Due to a vast variety of variables, they were divided into three groups: the co-morbidity and disease-related group, laboratory values and psychosocial and lifestyle factors as described in the current research on malnutrition development ([@ref32]). All three groups were comprised of variables, which were found to be statistically significant in the univariate regression analysis of low PA risk factors. Further analysis of the compounds of each group revealed the main risk factors of MN for cardiac surgery and, most importantly, provided the basis for early MN recognition and prevention for these patients. The results are concordant with the main mechanisms responsible for the development of MN and are discussed in literature: metabolic dysfunction and malabsorption, insufficient diet and the loss of nutrients via the digestive or urinary tracts ([@ref33]).

Amongst the co-morbidities and other disease- related factors, the most potent predictors of MN were renal and heart failure ([@ref34], [@ref35]). Both of these conditions can be either a cause or consequence of MN. Malnourished patients often have a decreased cardiac muscle mass, which results in a decrease of cardiac output and reduced renal perfusion. Furthermore, energy, micronutrient and electrolyte deficiencies cause changes in cytokines, glucocorticoids, insulin and insulin-like growth factors, which also result in decreased cardiac function. Congestive heart failure further reduces dietary intake and appetite sensation, creating the pathophysiological *circulus vitiosus* ([@ref36]).

There is an increasing evidence that neurohormonal and immune abnormalities play a crucial role in cardiac cachexia ([@ref33]). Studies have shown that this may be linked to raised plasma levels of inflammatory cytokines, such as tumour necrosis factor alpha, a possible result of cell hypoxia in heart failure ([@ref37]). Laboratory values related to MN were blood serum levels of haemoglobin, CRP and platelet count. These relationships reflect the multifactorial genesis of malnutrition ([@ref38]). The shortage of nutrients is reflected by the suppression of erythropoesis and thrombopoesis ([@ref39]). The increase of CRP levels is related to the chronic inflammation state of the undernourished tissues. All of these findings are concordant with the research on the origins of MN published in the ASPEN recommendations ([@ref38]). Therefore, it is important to account for these factors whilst preparing the patient for cardiac surgery and adjust the nutrition care, which has been shown to increase the PA ([@ref40]).

Psychosocial and lifestyle alterations add up to the complex nature of MN. In our study, psychological stress and neuropsychological problems, such as dementia or depression, are reported as risk factors of low PA ([@ref41]). These findings are in line with conventional risk factors of MN ([@ref42]). However, these variables are not independent from the mobility and food intake of the patient ([@ref43]). This emphasizes the strength of the relationship between these conditions and implies a need for proper psychological screening of patients before surgery.

Possible limitations of our study include general limitations of BIA and the specific nature of cardiac surgery patients. The regression equations used in BIA devices are based on measurements of healthy populations but are not adapted for unhealthy cardiac surgery populations. Moreover, the specificity of the studied population also contributes to the limited applicability of the results. These results may only be applied to cardiac surgery patients and must be further evaluated in alternative setting.

CONCLUSIONS {#sec5}
===========

It is clear that MN leads to adverse outcomes in cardiac surgery patients, therefore it is crucial to identify the modifiable risk factors at an early stage of preoperative management. MN risk factors comprise three different clinical groups: psychosocial and lifestyle factors, laboratory findings and disease-associated factors. The patients who are most likely to be malnourished are those with severe heart failure, valve pathology, insufficient renal function and high inflammatory markers. Also these patients have decreased mobility and food intake before surgery.

The authors are indebted to all patients who participated in the study.
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